Arnold Monto
#86,966
Most Influential Person Now
American professor of epidemiology
Arnold Monto's AcademicInfluence.com Rankings
Arnold Montomedical Degrees
Medical
#910
World Rank
#1173
Historical Rank
#307
USA Rank
Epidemiology
#132
World Rank
#143
Historical Rank
#32
USA Rank
Download Badge
Medical
Why Is Arnold Monto Influential?
(Suggest an Edit or Addition)According to Wikipedia, Arnold Monto is an American physician and epidemiologist. At the University of Michigan School of Public Health, Monto is the Thomas Francis, Jr. Collegiate Professor Emeritus of Public Health, professor emeritus of both epidemiology and global public health, and co-director of the Michigan Center for Respiratory Virus Research & Response. His research focuses on the occurrence, prevention, and treatment of viral respiratory infections in industrialized and developing countries' populations.
Arnold Monto's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The economic burden of non-influenza-related viral respiratory tract infection in the United States. (2003) (738)
- Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. (2001) (465)
- Acute respiratory illness in the community. Frequency of illness and the agents involved (1993) (462)
- Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials (2015) (436)
- Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures (2006) (429)
- Epidemiology of viral respiratory infections (2002) (419)
- Acute respiratory illness in an American community. The Tecumseh study. (1974) (396)
- Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use (2006) (379)
- Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. (2000) (371)
- Estimating household and community transmission parameters for influenza. (1982) (344)
- Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. (2010) (335)
- Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. (1999) (323)
- Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. (2014) (322)
- Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. (1970) (318)
- Nonpharmaceutical Interventions for Pandemic Influenza, International Measures (2006) (314)
- Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. (2004) (311)
- Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981. (1985) (305)
- Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity. (2021) (302)
- Clinical signs and symptoms predicting influenza infection. (2000) (298)
- Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 (2021) (285)
- Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. (2006) (282)
- Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. (1999) (281)
- Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020 (2020) (279)
- Comparative efficacy of inactivated and live attenuated influenza vaccines. (2009) (274)
- The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971. (1975) (266)
- Neuraminidase Inhibitor-Resistant Influenza Viruses May Differ Substantially in Fitness and Transmissibility (2005) (263)
- Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type (2014) (253)
- Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. (2012) (246)
- Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study (2022) (242)
- Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. (1992) (236)
- Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. (2011) (236)
- Low sensitivity of rapid diagnostic test for influenza. (2009) (231)
- Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 (2021) (227)
- Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. (2015) (225)
- Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season (2017) (219)
- 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. (2016) (213)
- Studies of the Community and Family: Acute Respiratory Illness and Infection (1994) (210)
- Textbook of Influenza (2013) (208)
- Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015 (2015) (204)
- The Tecumseh study of respiratory illness. VII. Further observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections. (1971) (197)
- Importance of Neuraminidase Active-Site Residues to the Neuraminidase Inhibitor Resistance of Influenza Viruses (2006) (194)
- The Tecumseh Study. XI. Occurrence of acute enteric illness in the community. (1980) (191)
- Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. (2005) (189)
- Facemasks, Hand Hygiene, and Influenza among Young Adults: A Randomized Intervention Trial (2012) (189)
- Effect of neuraminidase antibody on Hong Kong influenza. (1973) (182)
- Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. (1993) (182)
- Influenza vaccine effectiveness in the community and the household. (2013) (180)
- Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. (2007) (179)
- Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. (2002) (166)
- Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. (2002) (164)
- Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis. (1999) (163)
- Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013 (2013) (161)
- Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. (2016) (161)
- Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021 (2021) (160)
- Estimates of the US health impact of influenza. (1993) (158)
- Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. (2013) (155)
- Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. (2006) (154)
- Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. (2008) (153)
- Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic. (1969) (149)
- Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. (2001) (144)
- NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines? (2018) (143)
- Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018 (2018) (142)
- The Tecumseh study of respiratory illness. II. Patterns of occurrence of infection with respiratory pathogens, 1965-1969. (1971) (141)
- Stochastic processes constrain the within and between host evolution of influenza virus (2018) (139)
- Vaccines and Antiviral Drugs in Pandemic Preparedness (2006) (138)
- The Tecumseh Study of Respiratory Illness. VI. Frequency of and Relationship between Outbreaks of Coronavims Infection (1974) (135)
- Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. (2011) (128)
- HOST-PARASITE INTERACTION IN PATIENTS WITH INFECTIONS DUE TO ESCHERICHIA COLI. I. THE SEROGROUPING OF E. COLI FROM INTESTINAL AND EXTRAINTESTINAL SOURCES. (1964) (127)
- Occurrence of respiratory virus: time, place and person (2004) (127)
- The role of antivirals in the control of influenza. (2003) (123)
- Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. (2008) (123)
- Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan (2020) (122)
- Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes. (1987) (121)
- Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons (2018) (120)
- The Doctrine of Original Antigenic Sin: Separating Good From Evil (2017) (120)
- Detection and control of influenza outbreaks in well-vaccinated nursing home populations. (2004) (119)
- The seasonality of rhinovirus infections and its implications for clinical recognition (2002) (119)
- Influenza control in the 21st century: Optimizing protection of older adults. (2009) (118)
- Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. (1995) (116)
- Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities (2011) (116)
- Epidemiology of influenza. (2008) (115)
- A Comparison of 2 Influenza Vaccine Schedules in 6- to 23-Month-Old Children (2005) (113)
- Prevention of Russian influenza by amantadine. (1979) (111)
- Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season. (2019) (110)
- Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus. (2001) (108)
- Symptomatic predictors of influenza virus positivity in children during the influenza season. (2006) (108)
- Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. (2016) (106)
- Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. (2006) (104)
- The Tecumseh study of respiratory illness. I. Plan of study and observations on syndromes of acute respiratory disease. (1971) (101)
- Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States (2021) (101)
- Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017 (2017) (101)
- Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). (2013) (99)
- Influenza: quantifying morbidity and mortality. (1987) (96)
- Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility. (2015) (95)
- Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020 (2020) (95)
- Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials (2018) (94)
- Immunization With Trivalent Inactivated Influenza Vaccine in Partially Immunized Toddlers (2006) (94)
- Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. (1983) (93)
- Seasonal influenza and vaccination coverage. (2010) (93)
- Influenza Vaccine Immunogenicity in 6- to 23-Month-Old Children: Are Identical Antigens Necessary for Priming? (2005) (93)
- Nonpharmaceutical Influenza Mitigation Strategies, US Communities, 1918–1920 Pandemic (2006) (91)
- Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013 (2013) (91)
- Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination. (2015) (91)
- Medical reviews. Coronaviruses. (1974) (88)
- Pandemic Influenza: An Inconvenient Mutation (2009) (86)
- Frequency of Acute Respiratory Illnesses and Circulation of Respiratory Viruses in Households With Children Over 3 Surveillance Seasons (2014) (86)
- Evaluation of a cold-recombinant influenza virus vaccine in ferrets. (1982) (86)
- Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients. (2014) (86)
- The threat of an avian influenza pandemic. (2005) (85)
- Viral respiratory infections in the community: Epidemiology, agents, and interventions (1995) (84)
- Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season (2017) (82)
- Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project. (2000) (82)
- OSELTAMIVIR POST EXPOSURE PROPHYLAXIS INVESTIGATOR GROUP. EFFECTIVENESS OF OSELTAMIVIR IN PREVENTING INFLUENZA IN HOUSEHOLD CONTACTS: A RANDOMIZED CONTROLLED TRIAL (2001) (81)
- Epidemiology of viral respiratory infections☆ (2003) (81)
- Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine (2016) (80)
- Host-parasite interaction in patients with infections due to Escherichia coli. II. Serologic response of the host. (1965) (80)
- Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014 (2014) (79)
- Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019 (2019) (78)
- Ether treatment of type B influenza virus antigen for the hemagglutination inhibition test (1981) (78)
- Patterns and etiology of diarrhea in three clinical settings. (1984) (77)
- Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 (2013) (76)
- Norwalk virus enteric illness acquired by swimming exposure. (1982) (75)
- Implications of viral resistance to amantadine in control of influenza A. (1992) (74)
- Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses (2016) (73)
- Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research. (2010) (73)
- Influenza Transmission in a Cohort of Households with Children: 2010-2011 (2013) (73)
- Factors associated with influenza vaccine receipt in community dwelling adults and their children. (2014) (73)
- Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study (2018) (72)
- Community-wide Outbreak of Infection with a 229E-like Coronavirus in Tecumseh, Michigan (1970) (68)
- Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022 (2022) (68)
- Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults (1986) (67)
- The Tecumseh study of respiratory illness. V. Patterns of infection with the parainfluenzaviruses. (1973) (66)
- Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity. (1995) (64)
- Echinacea purpurea for Prevention of Experimental Rhinovirus Colds (2004) (64)
- Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. (1986) (64)
- Lessons From Influenza Pandemics of the Last 100 Years (2019) (64)
- The Tecumseh study of respiratory illness. 3. Incidence and periodicity of respiratory syncytial virus and Mycoplasma pneumoniae infections. (1971) (63)
- Intranasal Interferon-α2b for Seasonal Prophylaxis of Respiratory Infection (1986) (63)
- Effectiveness of Inactivated Influenza Vaccine Among Nursing Home Residents During an Influenza Type A (H3N2) Epidemic (1999) (63)
- Acute respiratory infection in children of developing countries: challenge of the 1990s. (1989) (62)
- The impact of vitamin A supplementation on morbidity: a randomized community intervention trial. (1991) (62)
- The risk of seasonal and pandemic influenza: prospects for control. (2009) (62)
- Acute respiratory illness in the community: effect of family composition, smoking, and chronic symptoms. (1977) (61)
- Vaccine use and the risk of outbreaks in a sample of nursing homes during an influenza epidemic. (1995) (61)
- Classification and Regression Tree (CART) analysis to predict influenza in primary care patients (2016) (60)
- Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States (2021) (59)
- Respiratory illness caused by picornavirus infection: a review of clinical outcomes (2001) (59)
- Interim estimates of 2017–18 seasonal influenza vaccine effectiveness — United States, February 2018 (2018) (59)
- Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 Viruses (2006) (58)
- Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection. (2019) (57)
- Controlled trial of enviroxime against natural rhinovirus infections in a community (1985) (57)
- Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010 (2011) (56)
- Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes (1995) (55)
- Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season. (2014) (53)
- Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021 (2022) (52)
- Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). (2018) (52)
- Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated. (2016) (52)
- Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness. (2006) (52)
- Influenza and COVID‐19: What does co‐existence mean? (2020) (51)
- Demographic and socioeconomic determinants of influenza vaccination disparities among university students (2009) (49)
- Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season. (2016) (48)
- The Tecumseh study of respiratory illness. VIII. Acute infection in chronic respiratory disease and comparison groups. (1975) (48)
- Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains (2016) (47)
- Respiratory syncytial virus hospitalization in middle-aged and older adults. (2017) (45)
- Interrupting the transmission of respiratory tract infections: theory and practice. (1999) (43)
- Effect of antigenic drift on influenza vaccine effectiveness in the United States - 2019-2020. (2020) (43)
- Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013. (2015) (41)
- Infant formulas and gastrointestinal illness. (1985) (41)
- Human coronaviruses and other respiratory infections in young adults on a university campus: Prevalence, symptoms, and shedding (2018) (41)
- Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. (2018) (41)
- The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review (2018) (40)
- Comment on “Seroevidence for H5N1 Influenza Infections in Humans: Meta-Analysis” (2012) (40)
- The Tecumseh Study of Respiratory Illness (2015) (40)
- Influenza pandemics: History and lessons learned (2013) (39)
- Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection. (1996) (39)
- The Importance of Sample Size in Studies Based upon the Serologic Classification of Escherichia coli. ∗ (1962) (39)
- A community study of respiratory infections in the tropics. I. Description of the community and observations on the activity of certain respiratory agents. (1967) (39)
- Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. (2006) (38)
- Expectations of Life: A Study in the Demography, Statistics, and History of World Mortality (1991) (38)
- Pandemic Influenza—Confronting a Reemergent Threat (1997) (38)
- Respiratory syncytial virus in a community population: circulation of subgroups A and B since 1965. (1990) (37)
- Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States (2018) (37)
- Milk fat and gastrointestinal illness. (1984) (37)
- Evaluation of an attenuated, cold-recombinant influenza B virus vaccine. (1982) (36)
- The Tecumseh Study of Illness. XIV. Occurrence of respiratory viruses, 1976-1981. (1986) (36)
- A discrete-time model for the statistical analysis of infectious disease incidence data. (1992) (36)
- Design and methods of a social network isolation study for reducing respiratory infection transmission: The eX-FLU cluster randomized trial (2016) (36)
- Influenza B Viruses Exhibit Lower Within-Host Diversity than Influenza A Viruses in Human Hosts (2019) (35)
- Seasonal and pandemic influenza: a 2007 update on challenges and solutions. (2008) (34)
- Middle-aged individuals may be in a perpetual state of H3N2 influenza virus susceptibility (2020) (34)
- Seasonal and pandemic influenza preparedness: a global threat. (2006) (33)
- Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States (2021) (33)
- Influenza Vaccine Effectiveness for Fully and Partially Vaccinated Children 6 Months to 8 Years Old During 2011–2012 and 2012–2013: The Importance of Two Priming Doses (2016) (33)
- Simulation studies of influenza epidemics: assessment of parameter estimation and sensitivity. (1984) (33)
- The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014–2015 Influenza Vaccine (2017) (32)
- The Tecumseh Study. XVI: Family and community sources of rotavirus infection. (1989) (32)
- The Tecumseh study. XII. Enteric agents in the community, 1976-1981. (1983) (32)
- Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015. (2016) (32)
- Assessment of development of resistance to antivirals in the ferret model of influenza virus infection. (2003) (32)
- Response of children to Neisseria meningitidis polysaccharide vaccines. (1973) (32)
- The Future of SARS-CoV-2 Vaccination - Lessons from Influenza. (2021) (31)
- Seroimmunity to poliomyelitis in an American community. (1975) (31)
- Influenza vaccine use among an elderly population in a community intervention. (1995) (31)
- Effect of zanamivir on duration and resolution of influenza symptoms. (2000) (30)
- A Study of Influenza and Influenza-Related Complications among Children in a Large US Health Insurance Plan Database (2012) (30)
- Statistical procedures for estimating the community probability of illness in family studies: rhinovirus and influenza. (1984) (29)
- Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France). (2013) (29)
- Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season. (2019) (29)
- Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans (2018) (29)
- The effect of reactive school closure on community influenza-like illness counts in the state of Michigan during the 2009 H1N1 pandemic. (2015) (28)
- Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families (1989) (28)
- Prospects for pandemic influenza control with currently available vaccines and antivirals. (1997) (28)
- Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapies. (2001) (28)
- The disappearance of Reye's syndrome--a public health triumph. (1999) (28)
- Global burden of influenza: what we know and what we need to know (2004) (28)
- Seasonal influenza vaccines: evolutions and future trends (2009) (27)
- Epidemiology of respiratory viruses in persons with and without asthma and COPD. (1995) (27)
- The Tecumseh study of respiratory illness. IV. Prevalence of rhinovirus serotypes, 1966-1969. (1972) (27)
- Antibody response to inactivated influenza vaccines of various antigenic concentrations. (1990) (27)
- Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials (2015) (26)
- Antivirals and influenza: frequency of resistance. (2008) (26)
- Prevalence and intensity of Schistosoma haematobium infection in six villages of upper Egypt. (1982) (26)
- Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study (2022) (26)
- Antivirals for influenza in healthy adults (2006) (25)
- Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015. (2017) (25)
- The Tecumseh study of respiratory illness. X. Relation of acute infections to smoking, lung function and chronic symptoms. (1978) (25)
- Epidemiology and Virology of Influenza Illness (2000) (24)
- Diagnostic testing for influenza: review of current status and implications of newer treatment options. (1999) (24)
- Influenza vaccines for the elderly. (1994) (24)
- Influenza vaccine effectiveness in inpatient and outpatient settings in the United States, 2015 - 2018. (2020) (24)
- Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine. (2012) (24)
- Preparing for Pandemic Influenza: Should Hospitals Stockpile Oseltamivir? (2005) (23)
- A community study of respiratory infections in the tropics. 3. Introduction and transmission of infections within families. (1968) (23)
- Response to the 2009 pandemic: Effect on influenza control in wealthy and poor countries (2011) (22)
- Relative efficacy of embryonated eggs and cell culture for isolation of contemporary influenza viruses (1981) (22)
- Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons—United States, 2011–2016 (2018) (21)
- Flexible Label-Free Quantitative Assay for Antibodies to Influenza Virus Hemagglutinins (2010) (21)
- Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020. (2020) (21)
- The Tecumseh Study. XV: Rotavirus infection and pathogenicity. (1989) (21)
- Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine. (2012) (21)
- Seasonal and pandemic influenza: recommendations for preparedness in the United States. (2006) (20)
- Findings, gaps, and future direction for research in nonpharmaceutical interventions for pandemic influenza. (2010) (20)
- Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022 (2022) (20)
- Psychiatric Interview Simulation by Computer (1967) (20)
- A community study of respiratory infections in the tropics. II. The spread of six rhinovirus isolates within the community. (1968) (20)
- Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017 (2020) (19)
- Respiratory infections in the American tropics. (1968) (19)
- Microneutralization Test for Detection of Rhinovirus Antibodies 1 (1974) (19)
- Acute respiratory infections (ARI) in children: prospects for prevention. (1998) (19)
- Detection of Coronavirus Infection of Man by Immunofluorescence 1 (1977) (19)
- Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS) (2019) (18)
- Severe morbidity among hospitalised adults with acute influenza and other respiratory infections: 2014–2015 and 2015–2016 (2018) (18)
- Home collection of nasal swabs for detection of influenza in the Household Influenza Vaccine Evaluation Study (2020) (18)
- Implications of antiviral resistance of influenza viruses. (2009) (18)
- Influenza (2022) (17)
- Preventing influenza in healthy adults: the evolving story. (2000) (17)
- An epidemiological study of Schistosoma haematobium and S. mansoni infection in thirty-five rural Egyptian villages. (1981) (17)
- Relative and absolute effectiveness of high-dose and standard-dose influenza vaccine against influenza-related hospitalization among older adults - United States, 2015-2017. (2020) (17)
- Susceptibility to rhinovirus infection in chronic bronchitis. (2015) (17)
- Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season. (2015) (17)
- Identification of human vaccinees that possess antibodies targeting the egg-adapted hemagglutinin receptor binding site of an H1N1 influenza vaccine strain (2018) (17)
- HL Cells, a Sensitive Line for the Isolation and Propagation of Respiratory Syncytial Virus 1 (1972) (17)
- Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations In Ovo (2018) (16)
- Liver function abnormalities in the course of a type A (H1N1) influenza outbreak: relation to Reye's syndrome. (1981) (16)
- The liver in ulcerative disease of the intestinal tract: functional and anatomic changes. (1959) (16)
- Efficacy of virucidal nasal tissues in interrupting familial transmission of respiratory agents. A field trial in Tecumseh, Michigan. (1988) (16)
- HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy (2019) (16)
- DEVELOPMENT OF COLD RECOMBINANTS OF INFLUENZA VIRUS AS LIVE VIRUS VACCINES (1981) (16)
- Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination. (2009) (15)
- Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016. (2018) (15)
- Mortality due to Reye's syndrome in Michigan: distribution and longitudinal trends. (1980) (15)
- Improving influenza vaccine effectiveness: ways to begin solving the problem. (2019) (15)
- Reflections on The Global Influenza Surveillance and Response System (GISRS) at 65 Years: An Expanding Framework for Influenza Detection, Prevention and Control (2018) (14)
- Invited commentary: Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy. (2003) (14)
- Waning vaccine effectiveness against influenza-associated hospitalizations among adults, 2015-2016 to 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network. (2021) (14)
- Immune-mediated attenuation of influenza illness after infection: opportunities and challenges. (2021) (14)
- Stress, adherence to preventive measures for reducing influenza transmission and influenza-like illness (2011) (14)
- Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population (2018) (14)
- Comparison of enzyme-linked immunosorbent assay and hemagglutination inhibition in a seroepidemiological study of influenza type C infection (1981) (14)
- Francis field trial of inactivated poliomyelitis vaccine: background and lessons for today. (1999) (13)
- The increasing prominence of household transmission of hepatitis A in an area undergoing a shift in endemicity (2005) (13)
- Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014–2015 (2015) (13)
- Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes. (2002) (13)
- Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel; 2015-16, 2016-17, and 2017-18. (2019) (13)
- Swine influenza vaccine program in the community: acceptability, reactions and responses. (1979) (13)
- Coronaviruses (2014) (13)
- Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon (1988) (13)
- Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons. (2015) (13)
- Application of an Individual-Based Transmission Hazard Model for Estimation of Influenza Vaccine Effectiveness in a Household Cohort (2017) (13)
- Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators (2021) (12)
- Serologic responses to nonprevalent influenza A viruses during intercyclic periods. (1981) (12)
- Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning. (2019) (11)
- A randomized intervention trial of mask use and hand hygiene to reduce seasonal influenza-like illness and influenza infections among young adults in a university setting (2010) (11)
- Moving Toward Improved Influenza Vaccines. (2017) (11)
- Individual and Community Impact of Influenza (2012) (11)
- Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United States (2022) (11)
- Development of a predictive index for picornavirus infections. (2003) (11)
- IN2: THE ECONOMIC BURDEN OF VIRAL RESPIRATORY INFECTION IN THE UNITED STATES (2001) (11)
- Asian influenza in the Panama Canal zone: isolation of a virus variant and protective effect of a vaccine containing A2/Japan/305/57. (1966) (11)
- Coronavirus Occurrence in the HIVE Cohort of Michigan Households: Reinfection frequency and serologic responses to seasonal and SARS coronaviruses. (2021) (10)
- Data resource profile: Household Influenza Vaccine Evaluation (HIVE) Study (2019) (10)
- Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses (2021) (10)
- The Global Threat of New and Reemerging Infectious Diseases: Reconciling U.S. National Security and Public Health Policy (2003) (10)
- Using antiviral agents to control outbreaks of influenza A infection. (1994) (10)
- THE SEROLOGIC SPECIFICITY OF CRUDE AND PURIFIED ANTIGEN EXTRACTS OF ESCHERICHIA COLI IN HEMAGGLUTINATION REACTIONS WITH RABBIT AND HUMAN ANTISERA. (1964) (10)
- The evolutionary dynamics of influenza A virus within and between human hosts (2017) (10)
- Frequency of arthralgia in women receiving one of three rubella vaccines. (1970) (10)
- History and epidemiological features of pandemic influenza. (2012) (9)
- Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community (2018) (9)
- Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2 (2020) (9)
- Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment (2021) (9)
- Relative effectiveness of high dose versus standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19. (2020) (9)
- Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18. (2020) (9)
- The Value of Influenza and Pneumococcal Vaccines in the Elderly (1996) (9)
- Editorial commentary: viral susceptibility and the choice of influenza antivirals. (2008) (9)
- Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network. (2020) (8)
- Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019. (2021) (8)
- Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness. (2017) (8)
- Effectiveness of Influenza Vaccines in the HIVE Household Cohort Over 8 Years: Is There Evidence of Indirect Protection? (2021) (7)
- Resistance of Influenza Virus to Antiviral Medications. (2020) (7)
- CLASSIFICATION OF SO-CALLED PARACOLON BACILLI ISOLATED FROM URINARY TRACT INFECTION. (1965) (7)
- Attenuated rubella vaccination in families: observations on the lack of fluorescent antibody response and on the use of blood collected on filter paper discs in the hemagglutination-inhibition test. (1969) (7)
- Study of Healthcare Personnel with Influenza and other Respiratory Viruses in Israel (SHIRI): study protocol (2018) (7)
- Seasonal influenza vaccinations: specialized products for different target groups. (2010) (7)
- Use of influenza vaccine in non-high risk populations. (1977) (7)
- Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017. (2018) (7)
- Neuraminidase Inhibitor Susceptibility Network Position Statement: Antiviral Resistance in Influenza A/H5N1 Viruses (2005) (7)
- Oseltamivir treatment for infl uenza in adults: a meta-analysis of randomised controlled trials (2015) (7)
- THE DEVELOPMENT AND CHARACTER OF BACTERIURIA IN PREGNANCY. EXPERIENCE WITH A NONINDIGENT POPULATION. (1963) (7)
- Seasonal patterns of acute infection in Tecumseh, Mich. (1970) (6)
- Protecting the herd from H1N1. (2009) (6)
- Stochastic processes dominate the within and between host evolution of influenza virus (2017) (6)
- Developments in Influenza Prevention and Treatment (2000) (6)
- Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022 (2022) (6)
- mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged >=16 Years in the United States, February to May 2021 (2021) (6)
- Influenza Vaccine Effectiveness in the Inpatient Setting; Evaluation of Potential Bias in the Test Negative Design by use of Alternate Control Groups. (2020) (6)
- Utilization and acceptability of influenza A/New Jersey/76 virus vaccine in Oakland County, Michigan. (1977) (5)
- Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness. (2017) (5)
- Influenza vaccine effectiveness against drifted versus vaccine-like A/H3N2 viruses during the 2014-15 influenza season—US Flu VE Network (2015) (5)
- Influenza Vaccination in Children with Asthma (2012) (5)
- Comparison of a frailty short interview to a validated frailty index in adults hospitalized for acute respiratory illness. (2019) (5)
- [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity]. (1994) (5)
- Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). (2020) (5)
- Reply: Letter to the editor, Cochrane rearranged. (2015) (5)
- Growth characteristics of influenza virus type C in avian hosts (2005) (4)
- Effectiveness of the live attenuated influenza vaccine: was additional of the second type B lineage a step too far? (2020) (4)
- Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011‐12—2015‐16 (2018) (4)
- Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness (2020) (4)
- Reducing Antibiotic Use in Ambulatory Care through Influenza Vaccination. (2020) (4)
- Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States (2022) (4)
- Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States (2022) (4)
- Influenza vaccine effectiveness among outpatients in the US Influenza Vaccine Effectiveness Network by study site 2011‐2016 (2020) (3)
- The common cold. Cold water on hot news. (1994) (3)
- Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season (2022) (3)
- Estimation procedures for transmission parameters from influenza epidemics: Use of serological data (1983) (3)
- Influenza resistance to zanamivir generated in ferrets (2001) (3)
- Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan (2021) (3)
- Updating the Approach to Influenza (2000) (3)
- Misconceptions concerning influenza: an overview and clear answers. (2006) (3)
- 16. Epidemiology of influenza (2013) (3)
- Effectiveness of the Neuraminidase Inhibitors: The Supporting Evidence Increases. (2019) (3)
- Oseltamivir for influenza – Authors' reply (2015) (3)
- Editorial commentary: seasonal influenza vaccines during the 2009 pandemic: help or harm? (2012) (2)
- The River: A Journey to the Source of HIV and AIDS (2001) (2)
- Vaccine effectiveness against COVID‐19 among symptomatic persons aged ≥12 years with reported contact with COVID‐19 cases, February–September 2021 (2022) (2)
- Agreement between state registry, health record, and self-report of influenza vaccination. (2021) (2)
- VIRAL RESPIRATORY TRACT INFECTIONS IN THE IMMUNOCOMPETENT (1996) (2)
- Acute respiratory infections in childhood prospects for vaccine prevention (2000) (2)
- The effective population size and mutation rate of influenza A virus in acutely infected individuals (2020) (2)
- Abdeljaber and Colleagues Respond (1993) (2)
- Author response: Stochastic processes constrain the within and between host evolution of influenza virus (2018) (2)
- Prior season vaccination and risk of influenza during the2014–2015 season in the U.S (2017) (2)
- Serologic Relationships of the B632 and ECHO-28 Rhinovirus Strains (1966) (2)
- Social patterning of acute respiratory illnesses in the Household Influenza Vaccine Evaluation (HIVE) Study 2014–2015 (2019) (2)
- The Clinical Efficacy of Influenza Vaccination (2012) (2)
- Workshop 1: Surveillance issues of pandemic influenza (1997) (2)
- Practical considerations in the diagnosis of myxovirus infections. (1972) (2)
- Role of Age in the Spread of Influenza, 2011–2019: Data From the US Influenza Vaccine Effectiveness Network (2022) (2)
- Role of Age in Spread of Influenza, 2011-2019, U.S. Influenza Vaccine Effectiveness Network. (2021) (2)
- Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants (2023) (1)
- SIP 1: Increasing the overall epidemic vaccination coverage. Epidemic vaccination coverage: it's a long way to Tipperary! (2009) (1)
- Epidemiology of RSV-A and RSV-B in Adults and Children with Medically-Attended Acute Respiratory Illness over Three Seasons (2022) (1)
- Controlled Trial ofEnviroxime Against Natural Rhinovirus Infections ina Community (1985) (1)
- Mitigation of Threats to the Continuation of Marine Recruit Training Posed by a Category 4/5 Influenza Pandemic (2007) (1)
- Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants (2022) (1)
- Demonstration ofDose-Response Relationship inSeasonal Prophylaxis ofRespiratory Infections withAlpha-2b Interferon (1988) (1)
- A Proposal to Refer to Four Coronaviruses of Limited Human Virulence “Common Cold Coronaviruses” (2022) (1)
- Current research on respiratory viral infections: XIII International Symposium on Respiratory Viral Infections: part 1 (2011) (1)
- How should influenza be treated? Focus on antivirals. (2015) (1)
- Immune history to influenza infection and vaccination predicts antibody responses to the seasonal influenza vaccine (2016) (1)
- Effect of Cyclic Nucleotide on Coronavirus Replication (1979) (1)
- Does early onset characterize autosomal dominant schizophrenia? (1993) (1)
- Outpatient Antibiotic Prescribing for Acute Respiratory Illnesses Including Influenza During the 2013-14 Influenza Season (2015) (1)
- Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States. (2021) (1)
- Disclosure of the Genetic Risk of Alzheimer's Disease (2010) (1)
- Prevention and drug treatment of influenza. (1983) (1)
- Vaccine effectiveness against acute respiratory illness hospitalizations for influenza-associated pneumonia during the 2015-2016 to 2017-2018 seasons, US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). (2021) (1)
- Antibodies against egg- and cell-grown influenza A(H3N2) viruses in adults hospitalized during the 2017-2018 season (2018) (1)
- The effect of influenza-like illness symptoms and laboratory confirmed influenza A on hand hygiene and other health habits among US University students (2010) (1)
- Transmission of viral pathogens in a social network of university students: the eX-FLU study (2020) (1)
- A History of Education in Public Health: Health That Mocks the Doctor's Rules (1992) (1)
- Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States. (2017) (1)
- Etiologic, pathophysiologic, symptomatic, therapeutic, and prognostic correlates of familiality in schizophrenia (1993) (1)
- Fear, Stress, and Reported Pandemic Influenza Response among University Students in the US (2008) (1)
- Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons. (2022) (1)
- Current research on respiratory viral infections: XIII International Symposium on Respiratory Viral Infections: part 2 (2011) (1)
- The first author replies (1992) (1)
- Reye's syndrome (1999) (0)
- Prepandemic influenza vaccines – Authors' reply (2009) (0)
- Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019. (2021) (0)
- Hepatitis A vaccine for secondary hepatitis A infection (1999) (0)
- SARS-CoV-2 Vaccine Strain Selection: Guidance from Influenza. (2022) (0)
- 1139Risk of influenza after Previous Acute Respiratory Illness in a Cohort of Households with Children (2014) (0)
- Oseltamivir and zanamivir are effective for treating influenza, but preventive effects are unclear (2003) (0)
- 995. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among High-Risk Adults in the United States, 2015–2016 (2018) (0)
- Influenza Viral Resistance to Antivirals (2006) (0)
- Influenza Vaccine Effectiveness among Elderly and Non-Elderly Adults Aged ≥45 Years in the United States, 2011–2012 to 2015–2016 (2017) (0)
- Immunized Toddlers Immunization With Trivalent Inactivated Influenza Vaccine in Partially (2013) (0)
- Relevance of RSV in hospitalized adults and the need for continued testing (2022) (0)
- The Future of SARS-CoV-2 Vaccination. Reply. (2022) (0)
- Reply to Sullivan and Kelly, and Skowronski, Janjua, and De Serres (2013) (0)
- Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022 (2022) (0)
- Influenza During the 2010–2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions (2022) (0)
- Respiratory virus circulation during the first year of the COVID‐19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort (2022) (0)
- Defining cellular correlates of protection and vaccine failure to influenza across two human cohorts (2021) (0)
- A rapid and flexible microneutralization assay for serological assessment of influenza viruses (2023) (0)
- Oseltamivir for influenza – Authors' reply (2016) (0)
- Comparing the Etiology of Viral Acute Respiratory Illnesses Between Children Who Do and Do Not Attend Childcare. (2023) (0)
- 533Persistence of Antibody to Influenza Hemagglutinin over Two Influenza Seasons (2014) (0)
- Universal hepatitis A vaccination of young children is leading to disappearance of hepatitis A in adolescents and adults (2003) (0)
- Influenza Antiviral Use Among High-Risk Outpatients During Four Recent Influenza Seasons—United States, 2011–2015 (2016) (0)
- SwineInfluenza Vaccine ProgramintheCommunity: Acceptability, Reactions andResponses (1979) (0)
- THERAPY OF VIRAL RESPIRATORY INFECTIONS (1999) (0)
- The Ghost of Years Past: The History of Influenza Vaccines (2018) (0)
- IDSA/ICAAC Joint Symposium: Susceptibility (2006) (0)
- Meet the Professors (2004) (0)
- Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March–November 2020 (2023) (0)
- Influenza Vaccine Effectiveness Among Children: 2011-2020. (2023) (0)
- The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade. (2022) (0)
- and chronic symptoms . family composition , smoking , the community : effect of Acute respiratory illness in (0)
- Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023. (2023) (0)
- 988. Effectiveness of Seasonal Influenza Vaccines Against Influenza A(H3N2) Illness Among Children Aged <18 Years, US Flu VE Network, 2010–2018 (2018) (0)
- Waning Influenza Vaccine Efficacy during the 2007-2008 Influenza Season (2015) (0)
- No Evidence of Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza A (H3N2) Viruses in a Household Cohort During the 2014–2015 Influenza Season (2016) (0)
- Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February–May 2021 (2021) (0)
- 997. Protection of Unvaccinated Individuals by Influenza Vaccine Coverage of Household Contacts (2018) (0)
- Community-Acquired Pneumonia in Adults Hospitalized With Acute Respiratory Illness During the 2014–2015 Influenza Season: Participant Characteristics and Viral Etiologies (2016) (0)
- Drs. Ohmit and Monto reply [3] (2007) (0)
- Relative Efficacy ofEmbryonated EggsandCell Culture for Isolation ofContemporary Influenza Viruses (1981) (0)
- Prevalence of antistreptolysin O in young Panamanians. (1969) (0)
- Influenza Vaccination and Treatment with Antiviral Agents Among Hospitalized Adults in the 2014–2015 and 2015–2016 Influenza Seasons (2017) (0)
- Comparative efficacy of influenza vaccines [3] (2010) (0)
- Comparisons of Respiratory Syncytial Virus (RSV) and Influenza: Population Characteristics and Clinical Outcomes in Hospitalized Adults (2022) (0)
- Safety and Efficacy of Long-Term Use of Rimantadine for Prophylaxis of Type A Influenza in Nursing Homes (1995) (0)
- Reply to Ringlander et al (2020) (0)
- Reply (2020) (0)
- International response to the H1N1 pandemic (2010) (0)
- 2734. Lack of Influence of Early Exposure to Influenza A(H3N2) Viruses on Vaccine Effectiveness Against A(H3N2)-Associated Illness in US Children <18 Years, 2016–2018 (2019) (0)
- The Epidemiology of Viral Infections (2010) (0)
- The pattern of cholangitis in the 1990s (1996) (0)
- Reply to Sullivan and Kelly and Skowronski et al. (2013) (0)
- PRS61 MEASURING RESPIRATORY SYNCYTIAL VIRUS (RSV) SYMPTOM INTENSITY AND IMPACT IN ADULTS: CONTENT VALIDITY ASSESSMENT OF A PATIENT-REPORTED OUTCOME (PRO) MEASURE: THE RSV INFECTION INTENSITY AND IMPACT QUESTIONNAIRE (RSV-IIIQ) (2020) (0)
- The Common Cold: The Effect of Hot Humid Air on the Nasal Mucosa-Reply (1994) (0)
- 650Relative Vaccine Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2–18 Years in Two Seasons – US Flu VE Network (2014) (0)
- Pure Politics and Impure Science: The Swine Flu Affair (1982) (0)
- Letters to the editor. (1969) (0)
- Clinical Influenza Testing Practices in Hospitalized Children at United States Medical Centers, 2015-2018. (2021) (0)
- Overcoming limitations of seasonal vaccines (2010) (0)
- Prevalence and Clinical Outcomes of Respiratory Syncytial Virus versus Influenza in Adults Hospitalized with Acute Respiratory Illness from a Prospective Multicenter Study. (2023) (0)
- 2760. Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012–2013 Through 2017–2018 (2019) (0)
- 1642. Comparing Viral Respiratory Infections Between Children Who Do and Do Not Attend Child Care (2019) (0)
- 座談会 Influenza: Current issues (2004) (0)
- Seasonal vaccination with the inactivated influenza vaccine generates antibody profiles that are distinct from those generated by the live-attenuated influenza vaccine (2016) (0)
- Next-Generation Sequencing of Influenza Viruses in a Household Cohort Accurately Identifies Transmission Pairs and Reveals a Bottleneck Size of Close to One (2016) (0)
- Epidemiologic designs for the study of acquired immunodeficiency disease: options and obstacles. (1984) (0)
- PREVALENCE OF ANTISTREPTOLYSIN 0 IN YOUNG PANAMANIANS (2007) (0)
- Influenza future: the impact of new vaccines and antivirals (2001) (0)
- Response to Ringlander. (2020) (0)
- [Procedures for estimating transmission parameters from influenza epidemics: use of serological data]. (1983) (0)
- 900. Effect of Influenza Vaccine Priming on Current Season Vaccine Effectiveness among Children and Adolescents, US Flu VE Network 2014–2015 Through 2017–2018 (2019) (0)
- New Vaccines: Introduction, Part 2 (1989) (0)
- 535Effectiveness of Seasonal Influenza Vaccines against Influenza A(H1N1)pdm09 Illness during Three Influenza Seasons, US Flu VE Network (2014) (0)
- K‐medoids clustering of hospital admission characteristics to classify severity of influenza virus infection (2023) (0)
- Influenza Vaccine Effectiveness in the 2014–2015 Season for Children 2-17 Years by Vaccine Type: US Influenza Vaccine Effectiveness Network (2015) (0)
- Effect of Cyclic Nucleotide on Coronavirus Replication (4051 6) (2003) (0)
- OralRimantadine Hydrochloride Therapy ofInfluenza A Virus H3N2Subtype Infection inAdults (1986) (0)
- Respiratory virus circulation during the first year of the COVID‐19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort (2023) (0)
- Ineffectiveness ofPostexposure Prophylaxis ofRhinovirus Infection withLow-DoseIntranasal Alpha2bInterferon inFamilies (1989) (0)
- The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade (2022) (0)
- Practice of Epidemiology Influenza Vaccine Effectiveness in the Inpatient Setting: Evaluation of Potential Bias in the Test-Negative Design by Use of Alternate Control Groups (2020) (0)
- PREVENTIVE CARE: Zanamivir Prevents Influenza (1999) (0)
- Controversies in Clinical Infectious Diseases - Part II (2003) (0)
- Response to Doshi et al. (2020) (0)
This paper list is powered by the following services:
Other Resources About Arnold Monto
What Schools Are Affiliated With Arnold Monto?
Arnold Monto is affiliated with the following schools:
